NCT00935025View on ClinicalTrials.gov

AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Healthy

Interventions

DRUG

AZD1305

single and multiple oral doses, extended-release capsule

DRUG

Placebo

single and multiple oral doses, capsule

Trial Locations (2)

Unknown

Research Site, Glendale

Research Site, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY